These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 17381432

  • 21. Plasmodium falciparum chloroquine resistance marker protein (Pfcrmp) may be a chloroquine target protein in nucleus.
    Li GD.
    Med Hypotheses; 2007; 68(2):332-4. PubMed ID: 16997492
    [Abstract] [Full Text] [Related]

  • 22. Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum.
    Radfar A, Diez A, Bautista JM.
    Free Radic Biol Med; 2008 Jun 15; 44(12):2034-42. PubMed ID: 18397762
    [Abstract] [Full Text] [Related]

  • 23. Inhibitory Mechanisms of DHA/CQ on pH and Iron Homeostasis of Erythrocytic Stage Growth of Plasmodium Falciparum.
    Tang T, Xu W, Ma J, Wang H, Cui Z, Jiang T, Li C.
    Molecules; 2019 May 20; 24(10):. PubMed ID: 31137574
    [Abstract] [Full Text] [Related]

  • 24. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
    Friebolin W, Jannack B, Wenzel N, Furrer J, Oeser T, Sanchez CP, Lanzer M, Yardley V, Becker K, Davioud-Charvet E.
    J Med Chem; 2008 Mar 13; 51(5):1260-77. PubMed ID: 18260613
    [Abstract] [Full Text] [Related]

  • 25. Distribution of acridine orange fluorescence in Plasmodium falciparum-infected erythrocytes and its implications for the evaluation of digestive vacuole pH.
    Bray PG, Saliba KJ, Davies JD, Spiller DG, White MR, Kirk K, Ward SA.
    Mol Biochem Parasitol; 2002 Feb 13; 119(2):301-4; discussion 307-9, 311-3. PubMed ID: 11814584
    [No Abstract] [Full Text] [Related]

  • 26. Malaria studies in vitro. IV: Chloroquine resistance and the intracellular pH of erythrocytes parasitised with Plasmodium berghei.
    Williams SG, Fanimo O.
    Ann Trop Med Parasitol; 1975 Sep 13; 69(3):301-9. PubMed ID: 239645
    [Abstract] [Full Text] [Related]

  • 27. Chloroquine and acid vesicle function.
    Krogstad DJ, Schlesinger PH, Gluzman IY.
    Prog Clin Biol Res; 1989 Sep 13; 313():53-9. PubMed ID: 2675117
    [Abstract] [Full Text] [Related]

  • 28. High-Content Screening of the Medicines for Malaria Venture Pathogen Box for Plasmodium falciparum Digestive Vacuole-Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery.
    Tong JX, Chandramohanadas R, Tan KS.
    Antimicrob Agents Chemother; 2018 Mar 13; 62(3):. PubMed ID: 29311064
    [Abstract] [Full Text] [Related]

  • 29. Chloroquine resistance is not associated with drug metabolism in Plasmodium falciparum.
    Berger BJ, Martiney J, Slater AF, Fairlamb AH, Cerami A.
    J Parasitol; 1995 Dec 13; 81(6):1004-8. PubMed ID: 8544038
    [Abstract] [Full Text] [Related]

  • 30. SELDI-TOF-MS analysis of chloroquine resistant and sensitive Plasmodium falciparum strains.
    Koncarevic S, Bogumil R, Becker K.
    Proteomics; 2007 Mar 13; 7(5):711-21. PubMed ID: 17295353
    [Abstract] [Full Text] [Related]

  • 31. Ultrastructure of Plasmodium falciparum "in vitro". I. Base-line for drug effects evaluation.
    Olliaro P, Castelli F, Milano F, Filice G, Carosi G.
    Microbiologica; 1989 Jan 13; 12(1):7-14. PubMed ID: 2654573
    [Abstract] [Full Text] [Related]

  • 32. Role for the plasmodium falciparum digestive vacuole in chloroquine resistance.
    Saliba KJ, Folb PI, Smith PJ.
    Biochem Pharmacol; 1998 Aug 01; 56(3):313-20. PubMed ID: 9744568
    [Abstract] [Full Text] [Related]

  • 33. Structural analysis of the anti-malaria active agent chloroquine under physiological conditions.
    Frosch T, Schmitt M, Bringmann G, Kiefer W, Popp J.
    J Phys Chem B; 2007 Feb 22; 111(7):1815-22. PubMed ID: 17256887
    [Abstract] [Full Text] [Related]

  • 34. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
    Nakornchai S, Konthiang P.
    Acta Trop; 2006 Dec 22; 100(3):185-91. PubMed ID: 17126280
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Uptake of [3H]chloroquine by drug-sensitive and -resistant strains of the human malaria parasite Plasmodium falciparum.
    Geary TG, Jensen JB, Ginsburg H.
    Biochem Pharmacol; 1986 Nov 01; 35(21):3805-12. PubMed ID: 3535803
    [Abstract] [Full Text] [Related]

  • 38. Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials.
    Zarchin S, Krugliak M, Ginsburg H.
    Biochem Pharmacol; 1986 Jul 15; 35(14):2435-42. PubMed ID: 3524576
    [Abstract] [Full Text] [Related]

  • 39. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
    Bacon DJ, Latour C, Lucas C, Colina O, Ringwald P, Picot S.
    Antimicrob Agents Chemother; 2007 Apr 15; 51(4):1172-8. PubMed ID: 17220424
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of Plasmodium falciparum pH regulation by small molecule indole derivatives results in rapid parasite death.
    van Schalkwyk DA, Chan XW, Misiano P, Gagliardi S, Farina C, Saliba KJ.
    Biochem Pharmacol; 2010 May 01; 79(9):1291-9. PubMed ID: 20067768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.